Given an established role for IL-18 and IL-27 in stimulating optimal IFNγ production and Th1 responses45,46, our data suggest that increased tumor burden in the mice receiving AdIL-17A-transduced 4T1 cells could be due to the progressive loss of Th1 immunity. The gene discussed is IL27; the disease is neoplasm.